SecBot SecBot
SECBOTREPLAY Home › Report › NRXP

NRXP · NRx Pharmaceuticals announced it will host a conference call to discuss…

NRx Pharmaceuticals, Inc. · PRESS-RELEASE filed Mar 19, 2026 at 07:00 ET

At the news

NEUTRALIMPACT 3/10

PRESS-RELEASE filed Mar 19, 2026 at 07:00 ET

NRx Pharmaceuticals announced it will host a conference call to discuss its fiscal year 2025 financial results and provide updates on its drug development programs, including NRX-100 and NRX-101. The press release contains no actual financial data, only forward-looking statements and procedural details about the earnings call.

  • NRx Pharmaceuticals will host an earnings call on March 24, 2026, to discuss FY2025 results.
  • No financial figures (revenue, EPS, etc.) were disclosed in the press release.
  • Company highlighted progress in drug development programs and regulatory designations for NRX-100 and NRX-101.
  • Forward-looking statements dominate the release; no material financial or operational data provided.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access